[Early detection in prostate cancer and shared decision making].
Screening of prostate cancer with PSA is a challenge for the aid to decision. Beside the rather mediocre characteristics of the screening test, there the additional problem of the peculiar biology of this cancer, with its late development and its ability to remain latent for a prolonged period. On the other hand, the treatment (surgery, irradiation) is associated with important side-effects: impotence and urinary leakage. Several studies, which appear to be a form of aid to information than aid to shared decision, have been carried out to analyse the effect of various modes of information on the behaviour of potential candidates to screening of prostate cancer, with the following results: better knowledge of the problem, lower rate of acceptance of PSA testing and trend towards watchful waiting rather than surgery in case of discovery of cancer.
Junod
A F
AF
Medizinischen Fakultät Genf.
D014408:Biomarkers, Tumor / Q000097:blood*; D003657:Decision Making; D042241:Early Diagnosis; D007172:Erectile Dysfunction / Q000209:etiology; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D010353:Patient Education as Topic; D010358:Patient Participation; D010817:Physician-Patient Relations; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D012307:Risk Factors; D014549:Urinary Incontinence / Q000209:etiology
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen